Protective effect of mesenchymal stem cell-conditioned medium on hepatic cell apoptosis after acute liver injury

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 5, 2013, Pages 831-840

  Xagorari, Angeliki ^a   Siotou, Eleni ^a   Yiangou, Minas ^b   Tsolaki, Eleftheria ^a,b   Bougiouklis, Dimitris ^a   Sakkas, Leonidas ^a   Fassas, Athanassios ^a   Anagnostopoulos, Achilles ^a  

^a Department of Histopathology   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

FGL1; Hepatic cell apoptosis; IL 6; Mesenchymal stem cell conditioned medium; Microparticles

Indexed keywords

CARBON TETRACHLORIDE; CULTURE MEDIUM; FGL1 PROTEIN, MOUSE; FIBRINOGEN; INTERLEUKIN 6; TRANSCRIPTOME;

ACUTE DISEASE; ANIMAL; APOPTOSIS; BIOSYNTHESIS; C57BL MOUSE; CULTURE MEDIUM; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; LIVER CELL; MALE; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; PHARMACOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXICITY;

ACUTE DISEASE; ANIMALS; APOPTOSIS; CARBON TETRACHLORIDE; CULTURE MEDIA, CONDITIONED; DRUG-INDUCED LIVER INJURY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRINOGEN; FLOW CYTOMETRY; HEPATOCYTES; INTERLEUKIN-6; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 84882989166     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Caplan A and Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006; 98: 1076-1084.
2. van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, Yarmush ML. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2004; 47: 1634-43.
3. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 2007; 104: 11002-7. Epub 2007 Jun 14.
4. Salazar KD, Lankford SM, Brody AR. Mesenchymal stem cells produce Wnt isoforms and TGF-beta1 that mediate proliferation and procollagen expression by lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2009; 297: L1002-11. Epub 2009 Sep 4.
5. Chen L, Tredget EE, Wu PYG, Wu Y. Paracrine factors of mesenchymal cells recruit macrophages and endothelial lineage cells and enhance wound healing. PloS ONE 2008; 3: 1-12.
6. Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW, Yarmush ML. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PloS ONE 2007; e941: 1-6.
7. Yannaki E, Athanasiou E, Xagorari A, Constantinou V, Batsis I, Kaloyannidis P, Proya E, Anagnostopoulos A, Fassas A. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol 2005; 33: 108- 19.
8. Bucher NL. Experimental aspects of hepatic regeneration. N Engl J Med 1967; 277: 738- 46.
9. Michalopoulos G. Liver regeneration. J Cell Physiol 2007; 213: 286-300.
10. Shi J, Aisaki K, Ikawa Y, Wake K. Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. Am J Pathol 1998; 153: 515-25.
11. Leu JI, Crissey MA, Taub R. Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice. J Clin Invest 2003; 111: 129-39.
12. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182: 1545-56.
13. Weil BR, Markel TA, Herrmann JL, Abarbanell AM, Meldrum DR. Mesenchymal stem cells enhance the viability and proliferation of human fetal intestinal epithelial cells following hypoxic injury via paracrine mechanisms. Surgery 2009; 146: 190-197.
14. Bansal MB, Kovalovich K, Gupta R, Li W, Agarwal A, Radbill B, Alvarez CE, Safadi R, Fiel MI, Friedman SL and Taub RA. Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression. J Hepatol 2005; 42: 548-556.
15. Kovalovich K, Li W, DeAngelis R, Greenbaum L, Cilberto G, Taub R. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-XL. J Biol Chem 2001; 276: 26605-26613.
16. Yun JW, Kim CW, Bae IH, Park YH, Chung JH, Lim KM, Kang KS. Determination of the key innate genes related to individual variation in carbon tetrachloride-induced hepatotoxicity using a pre-biopsy procedure. Toxicol Appl Pharmacol 2009; 239: 55-63. Epub 2009 May 27.
17. Yu HT, Yu M, Li CY, Zhan YQ, Xu WX, Li YH, Li W, Wang ZD, Ge CH, Yang XM. Specific expression and regulation of hepassocin in the liver and down-regulation of the correlation of HNF1a with decreased levels of hepassocin in human hepatocellular carcinoma. J Biol Chem 2009; 284: 13335-13347.
18. Yan J, Ying H, Gu F, He J, Li YL, Liu HM, Xu YH. Cloning and characterization of a mouse liverspecific gene mfrep-1, upregulated in liver regeneration. Cell Res 2002; 12: 353-361.
19. Liu Z and Ukomadu C. Fibrinogen-like-protein 1, a hepatocyte derived protein is an acute phase reactant. Biochem Biophys Res Commun 2008; 365: 729-734.
20. Hara H, Uchida S, Yoshimura H, Aoki M, Toyoda Y, Sakai Y, Morimoto S, Fukamachi H, Shiokawa K, Hanada K. Isolation and characterization of a novel liver-specific gene, hepassocin, upregulated during liver regeneration. Bioc Biophysica Acta 2000; 1492: 31-44.
21. Tetta C, Fonsato V, Deregibus MC, Camussi G. The role of microvesicles in tissue repair. Organogenesis 2001; 7: 105-115.
22. Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, Lim SK. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res 2010; 38: 215-24.
23. Herrera MB, Fonsato V, Gatti S, Deregibus MC, Sordi A, Cantarella D, Calogero R, Bussolati B, Tetta C, Camussi G. Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med 2010; 14: 1605-1618.
24. Otsuka T, Takagi H, Horiguchi N, Toyoda M, Sato K, Takayama H, Mori M. CCl4-induced acute liver injury in mice is inhibited by hepatocyte growth factor overexpression but stimulated by NK2 overexpression. FEBS Lett 2002; 532: 391-5.
25. Klaunig JE, Goldblatt PJ, Hinton DE, Lipsky MM, Chacko J, Trump BF. Mouse liver culture. In vitro 1981; 17: 913-925.
26. Sun S, Guo Z, Xiao X, Liu B, Liu X, Tang PH, Mao N. Isolation of Mouse Marrow Mesenchymal Progenitors by a Novel and Reliable Method. Stem Cells 2003; 21: 527-535.
27. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 2006; 24: 462-71.
28. Wuestefeld T, Klein C, Streetz KL, Betz U, Lauber J, Buer J, Manns MP, Müller W and Trautwein C. Interleukin-6/Glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 2003; 278: 11281- 11288.
29. Gnecchi M, He H, Melo LG, Noiseaux N, Morello F, de Boer RA, Zhang L, Pratt RE, Dzau VJ, Ingwall JS. Early beneficial effects of bone marrow- derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells 2009; 27: 971-9.
30. Tögel FE, Westenfelder C. Mesenchymal stem cells: a new therapeutic tool for AKI. Nat Rev Nephrol 2010; 6: 179-83.
31. Li CY, Cao CZ, Xu WX, Cao MM, Yang F, Dong L, Yu M, Gao YB, Li W, Wang ZD, Ge CH, Wang QM, Peng RY, Yang XM. Recombinant human hepasoccin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure. Gut 2010; 59: 817- 826.